2012
DOI: 10.1002/jps.23199
|View full text |Cite
|
Sign up to set email alerts
|

Release Behavior of Tanshinone IIA Sustained-Release Pellets Based on Crack Formation Theory

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 33 publications
0
1
0
Order By: Relevance
“…By 48 h, nearly full gathering is achieved, resulting in 94.99% light transmittance in the side of the Petri dish, and the nanocomposite also showed a sustained release profile with 20 h time for blood clot dissolution compared to free nattokinase, and the nanocomposite formed on the study also showed good storage ability. 171 To explore more iron oxide nanoparticle benefits on thrombolysis treatment, Cabrera et al used superparamagnetic heating of iron oxide nanoparticles to aid the blood clot dissolution while also using tPA as the primary clot dissolution agent; in this test, whole human blood was stimulated to clot by the addition of adenosine diphosphate (ADP) used as the test bed, in a blood clot that is treated using MHT combined with tPA visibly seen to be more disrupted with more red blood cell (RBC) sediment compared to the blood clot that is treated with tPA alone. This also was validated with the blood clot mass that is reduced to 75.6% with MHT combined tPA compared to 81.3% with tPA only.…”
Section: Iron Oxides Nanorobot For Disease Healing and Treatmentmentioning
confidence: 99%
“…By 48 h, nearly full gathering is achieved, resulting in 94.99% light transmittance in the side of the Petri dish, and the nanocomposite also showed a sustained release profile with 20 h time for blood clot dissolution compared to free nattokinase, and the nanocomposite formed on the study also showed good storage ability. 171 To explore more iron oxide nanoparticle benefits on thrombolysis treatment, Cabrera et al used superparamagnetic heating of iron oxide nanoparticles to aid the blood clot dissolution while also using tPA as the primary clot dissolution agent; in this test, whole human blood was stimulated to clot by the addition of adenosine diphosphate (ADP) used as the test bed, in a blood clot that is treated using MHT combined with tPA visibly seen to be more disrupted with more red blood cell (RBC) sediment compared to the blood clot that is treated with tPA alone. This also was validated with the blood clot mass that is reduced to 75.6% with MHT combined tPA compared to 81.3% with tPA only.…”
Section: Iron Oxides Nanorobot For Disease Healing and Treatmentmentioning
confidence: 99%
“…Several materials were applied to the TNIIA pellets with sustained release, including hydroxypropyl methylcellulose (HPMC) and surelease, 113 PVP and F68, 115 polyvinyl acetate (PVAc), and poly(vinyl alcohol)poly(ethylene glycol) (PVA-PEG) graft copolymer. 116 In addition, d-alpha-tocopheryl polyethylene glycol succinategraft-PLGA (TPGS-g-PLGA) copolymer and F68 were used to form mixed micelles with improved bioavailability and prolonged circulation times against hepatocellular carcinoma. 114 However, neither of these formulations had a targeted delivery system for the improved cellular uptake of TNIIA.…”
Section: Othersmentioning
confidence: 99%